Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Simiao Yong'an Soup
- Development stage
- Preclinical
- Lead developer
- Xiyuan Hospital
- Administration
- Oral
01
Overview
Modified Simiao Yong'an Soup is a traditional Chinese medicine (TCM) formula derived from the classic Simiao Yong'an Decoction. It is currently under investigation for the treatment of non-infectious uveitis. The base formula, Simiao Yong'an Decoction, is recognized for its multi-targeted therapeutic actions, including anti-inflammatory, anti-apoptotic, and immunomodulatory effects. It has been shown to modulate various signaling pathways involved in inflammation, cell survival, and angiogenesis. This herbal preparation is typically administered orally.
- Other names
- Modified Simiao Yong'an Soup Recipe GranulesSi-Miao-Yong-An DecoctionSMYAD
02
Targets
AGER (RAGE)ATM (Ataxia telangiectasia mutated protein)CCL2 (C-C motif chemokine 2)CXCL1 (C-X-C motif chemokine ligand 1)CXCL2 (C-X-C motif chemokine ligand 2)CCND1 (Cyclin D1)CDK4 (Cyclin-dependent kinase 4)FGF2HDAC1 (Histone Deacetylase 1)HIF1A (Hypoxia-inducible factor 1-alpha)ICAM1 (Intercellular Adhesion Molecule 1)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)IL8 (C-X-C Motif Chemokine Ligand 8)JAK1 (Janus kinase 1)MMP9 (Matrix metalloproteinase-9)MAPK3 (Mitogen-activated protein kinase 1)NOX4 (NADPH oxidase 4)NF-κBPPARG (Peroxisome proliferator-activated receptor gamma)PDE5 (Phosphodiesterase 5A)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)PDGFRB (Platelet-derived growth factor receptor beta)AKT (RAC-alpha serine/threonine-protein kinase)TLR4 (Toll-like receptor 4)TGFB1 (Transforming growth factor Beta-1 proprotein)TNFA (Tumor necrosis factor alpha (soluble))VCAM1 (Vascular cell adhesion molecule 1)VEGFA (Vascular endothelial growth factor A)VEGFR2 (Vascular endothelial growth factor receptor 2)
Beyond the preview
Go deeper on Modified Simiao Yong'an Soup.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Modified Simiao Yong'an Soup.